The Clinical Consequences of Stimulant Use: Focus on Intoxication, Washout, and Therapies

Friday, April 5, 2024

10:30 AM – 11:45 AM

Presenter(s)

JoAn Laes, MD, DFASAM

Addiction Medicine Physician, Medical Toxicologist
Allina Health, Minnesota

Slides
Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM

Director of Addiction Medicine in the Department of Emergency Medicine & Program Director URMC Medical Toxicology Fellowship
University of Rochester Medical Center, New York
Jeremiah D. Fairbanks, DO, FASAM

Physician
Allina Health, Minnesota
Ian Latham, MD

Addiction Medicine Fellow
Univeristy of Minnesota, Minnesota

Non-presenting author(s)

Robert Cole Pueringer, MD, FASAM

Medical Toxicologist, Addiction Medicine Specialist, Hospitalist
Essentia Health, Minnesota
Lewis S. Nelson, MD, MBA, FASAM

Chair
Rutgers New Jersey Medical School, New Jersey
Emily Brunner, MD, DFASAM

Physician Consultant
Hazelden Betty Ford Foundation, Minnesota

This focus session will describe the neurobiological effects of stimulants and provide clinicians with tools for assessment and management of stimulant intoxication and other adverse effects from stimulants, such as physiological effects of abstinence from stimulants. We will provide information on laboratory testing for stimulants and the utility of testing. We shall also review the pharmacology and adverse effects of medications used in the treatment of stimulant use disorder including naltrexone, bupropion, modafinil, and mixed amphetamine salts.

Learning Objectives:

Learners will be able to:

Describe the neurobiological effects of various stimulant classes
Explain how to assess (including laboratory testing and analysis) and manage stimulant toxicity and wash out syndromes related to stimulant abstinence
Highlight the pharmacology and adverse effects of medications used in the treatment of stimulant intoxication and stimulant use disorder